China has reported 460 human infections with the H7N9 avian flu virus since last October, more than in any year since the novel virus emerged there in 2013, the Centers for Disease Control and Prevention announced last week. During the prior years, 88% of patients developed pneumonia, 68% were admitted to an intensive care unit and 41% died. H7N9 viruses have not been detected in people or birds in the United States and currently pose low risk to public health, CDC said. However, the agency is using reverse genetics to prepare a candidate vaccine virus and will continue to track the virus’ potential for pandemic risk. For more on the H7N9 virus, including guidance for U.S. clinicians, visit www.cdc.gov

Related News Articles

Perspective
Public
The 2025 AHA Leadership Summit wrapped up on July 22, and as always, it was energizing and inspiring to connect with so many talented and dedicated people…
Headline
The AHA July 24 announced it is collaborating with health care technology leader Epic to help hospitals adopt tools that support the early detection and…
Headline
The Department of Health and Human Services July 23 announced it is recommending the removal of thimerosal from all U.S. flu vaccines. The announcement follows…
Headline
Carolyn Bogard, DNP, R.N., director of care coordination and palliative care at El Camino Health, talks about her system’s use of data to harness the passion…
Headline
The Food and Drug Administration has identified a Class I recall of certain lots of Medline Industries Craniotomy Kits containing recalled Codman…
Headline
Hartford HealthCare in Hartford, Conn., will receive the 2025 AHA Quest for Quality Prize as a result of their sweeping transformation over the past decade —…